Loomis Sayles Global Growth Fund OCSE:NOVO B Holdings History
Loomis Sayles Global Growth Fund's Novo Nordisk AS Holding Summary
As of 2025-02-28, Natixis Funds Trust II held 30,877.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr2.80 Mil. This investment constitutes 2.54% of their stock portfolio, and Natixis Funds Trust II now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q4. And since then Loomis Sayles Global Growth Fund has made 11 purchases of OCSE:NOVO B, at an average price of kr229.91, for a total of 114,691.00 shares. In addition, there have been 10 sales at an average price of kr284.53 for 83,814.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, Loomis Sayles Global Growth Fund's estimated gain on his OCSE:NOVO B holdings is kr10.57 Mil, reflecting a 40.08% gain to date.
Loomis Sayles Global Growth Fund OCSE:NOVO B (kr423.90) Holding Chart
Loomis Sayles Global Growth Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
